Evaluation Of tuberculin skin test and booster effect in hemodialysis patients
| Author | Masomeh Alimagham | en |
| Author | Saied Aminiafshar | en |
| Author | Latif Gachkar | en |
| Author | Kamran Sharafim | en |
| Author | Mohammad Farahbakhsh | en |
| Issued Date | 2006-01-31 | en |
| Abstract | Background: Tuberculosis is an endemic disease in Iran which may occur more frequently among hemodialysis patients. We have evaluated tuberculin skin test (TST) in hemodialysis patients in a university hospital in 2003-2004. : Sixty-seven hemodialyis patients were enrolled for tuberculin skin tests. Indurations were measured 48-72 hours after the injection and then on the 7th day. Those with indurations less than 5mm in TST1 were introduced for TST2. Results: Of 67 patients, 18(26.9%) had indurations of less than 5mm in TST1 and were introduce for TST2 among whom 7 (39%) had an induration measured less than 5mm. Of 18 cases, 11 (61%) were revealed to have booster effect that represent a ratio of 16% of all studied hemodialysis patients in our study. Conclusion: It seems that the second TST is a better indicator of infectivity in hemodialysis patients, especially for patients who require repeated or annual estimation for M. tuberculosis infection. | en |
| DOI | https://doi.org/ | en |
| Keyword | Hemodialysis | en |
| Keyword | Booster effect | en |
| Keyword | Tuberculosis | en |
| Keyword | Tuberculin skin test | en |
| Publisher | Brieflands | en |
| Title | Evaluation Of tuberculin skin test and booster effect in hemodialysis patients | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 76560-pdf.pdf
- Size:
- 148.35 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF